For decades, the success of breast cancer treatment was measured by a singular, albeit vital, metric: survival....
Basiran
By Industry Analysis Desk Published September 28, 2026 In a strategic recalibration that underscores the intensifying competition...
LA JOLLA, CA – May 12, 2025 – In a landmark discovery poised to redefine the treatment...
In a significant move aimed at reshaping the landscape of medical research, METAvivor—a leading voice in the...
For Sergio Flores, Pride is not merely a seasonal celebration or a colorful parade; it is a...
For patients navigating the emotional and physical complexities of breast reconstruction following a cancer diagnosis or prophylactic...
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between...
The pharmaceutical industry stands at a critical juncture. As clinical trial protocols grow exponentially in complexity—now capturing...
In the modern American economy, the tension between professional obligations and personal health is reaching a breaking...
The landscape of oncology is currently at a critical intersection. For decades, the medical community has relied...
